Cargando…
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis
BACKGROUND: Lung cancer is considered a terminal illness with a five-year survival rate of about 16%. Informed decision-making related to the management of a disease requires accurate prognosis of the disease with or without treatment. Despite the significance of disease prognosis in clinical decisi...
Autores principales: | Wao, Hesborn, Mhaskar, Rahul, Kumar, Ambuj, Miladinovic, Branko, Djulbegovic, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579762/ https://www.ncbi.nlm.nih.gov/pubmed/23379753 http://dx.doi.org/10.1186/2046-4053-2-10 |
Ejemplares similares
-
Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review
por: Mhaskar, Rahul S, et al.
Publicado: (2014) -
Benchmarks for detecting ‘breakthroughs’ in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimation
por: Miladinovic, Branko, et al.
Publicado: (2014) -
A Flexible Alternative to the Cox Proportional Hazards Model for Assessing the Prognostic Accuracy of Hospice Patient Survival
por: Miladinovic, Branko, et al.
Publicado: (2012) -
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance
por: Miladinovic, Branko, et al.
Publicado: (2011) -
When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members
por: Mhaskar, Rahul, et al.
Publicado: (2016)